Wellington Management Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $226M | Sell |
|
|||||
|
2025
Q2 | $167M | Sell |
|
|||||
|
2025
Q1 | $238M | Buy |
|
|||||
|
2024
Q4 | $268M | Buy |
|
|||||
|
2024
Q3 | $256M | Buy |
|
|||||
|
2024
Q2 | $209M | Buy |
|
|||||
|
2024
Q1 | $222M | Buy |
|
|||||
|
2023
Q4 | $216M | Buy |
|
|||||
|
2023
Q3 | $91.5M | Sell |
|
|||||
|
2023
Q2 | $98.2M | Buy |
|
|||||
|
2023
Q1 | $83.3M | Sell |
|
|||||
|
2022
Q4 | $99M | Buy |
|
|||||
|
2022
Q3 | $84.1M | Sell |
|
|||||
|
2022
Q2 | $118M | Sell |
|
|||||
|
2022
Q1 | $252M | Sell |
|
|||||
|
2021
Q4 | $308M | Buy |
|
|||||
|
2021
Q3 | $232M | Buy |
|
|||||
|
2021
Q2 | $151M | Buy |
|
|||||
|
2021
Q1 | $139M | Buy |
|
|||||
|
2020
Q4 | $234M | Buy |
|
|||||
|
2020
Q3 | $84.8M | Sell |
|
|||||
|
2020
Q2 | $101M | Buy |
|
|||||
|
2020
Q1 | $43.3M | Sell |
|
|||||
|
2019
Q4 | $49M | Sell |
|
|||||
|
2019
Q3 | $62.1M | Sell |
|
|||||
|
2019
Q2 | $104M | Buy |
|
|||||
|
2019
Q1 | $105M | Buy |
|
|||||
|
2018
Q4 | $72.5M | Buy |
|
|||||
|
2018
Q3 | $84.6M | Sell |
|
|||||
|
2018
Q2 | $126M | Sell |
|
|||||
|
2018
Q1 | $124M | Buy |
|
|||||
|
2017
Q4 | $79.6M | Sell |
|
|||||
|
2017
Q3 | $91.4M | Buy |
|
|||||
|
2017
Q2 | $60.3M | Buy |
|
|||||
|
2017
Q1 | $38.1M | Buy |
|
|||||
|
2016
Q4 | $5.79M | Buy |
|
|||||
|
2016
Q3 | $8.17M | Buy |
|
|||||
|
2016
Q2 | $5.95M | Buy |
|
|||||
|
2016
Q1 | $8.78M | Sell |
|
|||||
|
2015
Q4 | $10.1M | Buy |
|
|||||
|
2015
Q3 | $14M | Buy |
|
|||||
|
2015
Q2 | $14M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $3.31M | Buy |
|